Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly

Increasingly, clinical trials for Alzheimer’s disease (AD) are being conducted earlier in the disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau and Aβ measures to quantify pathology. However, making such a pre-clinical AD diagnosis is relatively costly and th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Alzheimers Dis
Hauptverfasser: Westwood, Sarah, Leoni, Emanuela, Hye, Abdul, Lynham, Steven, Khondoker, Mizanur R., Ashton, Nicholas J., Kiddle, Steven J., Baird, Alison L., Sainz-Fuertes, Ricardo, Leung, Rufina, Graf, John, Hehir, Cristina Tan, Baker, David, Cereda, Cristina, Bazenet, Chantal, Ward, Malcolm, Thambisetty, Madhav, Lovestone, Simon
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5898378/
https://ncbi.nlm.nih.gov/pubmed/27031486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-151155
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge